Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRS | BDX | MCK | ABC | WST |
| Company | Antares Pharma | Becton Dickinson and Company | Mckesson Corp | Amerisourcebergen Corp | West Pharmaceutical Services |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 5.58 | 235.00 | 556.27 | 180.93 | 365.35 |
| High | 5.60 | 236.32 | 560.49 | 180.93 | 372.52 |
| Low | 5.58 | 233.73 | 556.13 | 179.24 | 364.04 |
| Last | 5.59 | 235.67 | 559.91 | 179.98 | 364.19 |
| Change | unch | +0.67 | +4.79 | -0.41 | -1.40 |
| % Change | unch | +0.29% | +0.86% | -0.23% | -0.38% |
| Volume | 2,707,400 | 2,034,300 | 636,800 | 806,000 | 488,200 |
| 20-Day Average Volume | 3,885,230 | 1,424,720 | 764,610 | 2,493,280 | 505,250 |
| Previous Close | 5.59 | 235.00 | 555.12 | 180.39 | 365.59 |
| Industry | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.57 | 234.20 | 534.99 | 183.65 | 370.25 |
| 20-Day Raw Stochastic | 83.33% | 45.19% | 88.08% | 16.43% | 27.44% |
| 20-Day Relative Strength | 76.57% | 48.60% | 65.61% | 41.63% | 44.29% |
| Weighted Alpha | +30.00 | -8.00 | +45.51 | +20.60 | -0.04 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | 40% Buy | 40% Sell |
| Previous Opinion | 100% Buy | 88% Sell | 100% Buy | 40% Buy | 8% Buy |
| Last Month's Opinion | 88% Buy | 8% Sell | 80% Buy | 80% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.36% since 05/16/22 | +0.42% since 05/03/24 | +5.87% since 05/03/24 | +1.14% since 08/22/23 | -0.23% since 05/03/24 |
| Low | 5.57 on 05/18/22 | 233.18 on 05/08/24 | 530.80 on 05/06/24 | 177.15 on 08/23/23 | 354.62 on 05/09/24 |
| High | 5.60 on 05/23/22 | 239.57 on 05/07/24 | 566.01 on 05/08/24 | 180.93 on 08/29/23 | 372.52 on 05/10/24 |
| 1-Month | |||||
| %Chg | +0.36% since 04/22/22 | -2.21% since 04/10/24 | +5.65% since 04/10/24 | -3.53% since 07/28/23 | -6.56% since 04/10/24 |
| Low | 5.54 on 05/12/22 | 229.40 on 04/17/24 | 514.88 on 04/18/24 | 177.15 on 08/23/23 | 352.76 on 04/30/24 |
| High | 5.60 on 05/23/22 | 243.30 on 04/11/24 | 566.01 on 05/08/24 | 194.37 on 08/03/23 | 394.42 on 04/24/24 |
| 3-Month | |||||
| %Chg | +65.88% since 02/23/22 | -3.31% since 02/09/24 | +11.68% since 02/09/24 | +6.87% since 05/26/23 | -11.10% since 02/09/24 |
| Low | 3.24 on 02/24/22 | 229.40 on 04/17/24 | 493.97 on 02/12/24 | 163.37 on 05/31/23 | 325.73 on 02/15/24 |
| High | 5.60 on 05/23/22 | 248.42 on 03/28/24 | 566.01 on 05/08/24 | 194.79 on 07/21/23 | 409.72 on 02/12/24 |
| 6-Month | |||||
| %Chg | +63.93% since 11/23/21 | +0.43% since 11/10/23 | +19.31% since 11/10/23 | +15.70% since 02/28/23 | +6.60% since 11/10/23 |
| Low | 3.11 on 01/28/22 | 229.40 on 04/17/24 | 431.35 on 12/15/23 | 147.48 on 03/15/23 | 325.73 on 02/15/24 |
| High | 5.60 on 05/23/22 | 249.89 on 01/09/24 | 566.01 on 05/08/24 | 194.79 on 07/21/23 | 413.70 on 02/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 955,063 | 67,916,416 | 72,947,208 | 36,387,456 | 26,630,672 |
| Shares Outstanding, K | 170,852 | 289,006 | 131,408 | 202,175 | 72,843 |
| Annual Sales | 183,980,000 | 19,372,000,000 | 276,711,000,000 | 238,587,000,000 | 2,949,800,000 |
| Annual Net Income | 46,290,000 | 1,484,000,000 | 3,560,000,000 | 1,698,820,000 | 593,400,000 |
| Last Quarter Sales | 41,560,000 | 5,045,000,000 | 80,898,000,000 | 66,947,050,000 | 695,400,000 |
| Last Quarter Net Income | -2,320,000 | 537,000,000 | 589,000,000 | 479,580,000 | 115,300,000 |
| 60-Month Beta | 1.15 | 0.45 | 0.45 | 0.56 | 1.05 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 05/10/22 | 3.17 on 05/02/24 | 6.18 on 05/07/24 | 2.92 on 08/02/23 | 1.56 on 04/25/24 |
| Latest Earnings Date | 05/19/22 | 05/02/24 | 05/07/24 | 08/02/23 | 04/25/24 |
| Most Recent Dividend | N/A | 0.950 on 03/07/24 | 0.620 on 02/29/24 | 0.485 on 08/10/23 | 0.200 on 04/23/24 |
| Next Ex-Dividends Date | N/A | 06/07/24 | 05/31/24 | 08/10/23 | 07/31/24 |
| Ratios | |||||
| Price/Earnings ttm | 79.86 | 19.10 | 19.83 | 15.38 | 47.87 |